Waystar Holding Corp.

https://investors.waystar.com/

Waystar Holding Corp. is a leading provider of cloud-based software solutions designed to simplify and unify healthcare payments and revenue cycle management (RCM) for healthcare providers. The company's core mission is to transform healthcare payments, enabling providers to concentrate on patient care by reducing administrative burdens and fostering financial growth. Waystar maintains co-headquarters in Lehi, Utah, and Louisville, Kentucky, and was established in 2017 through the merger of Navicure and ZirMed, with its incorporation in Delaware.

The company offers a comprehensive platform that addresses the entire revenue cycle, encompassing financial clearance, patient financial care, claim and payer payment management, denial prevention and recovery, clinical integrity, revenue capture, and advanced analytics and reporting. Waystar leverages artificial intelligence (AI) and advanced automation to streamline financial processes, enhance operational efficiency, and improve the financial health of its clients. Its solutions serve a broad market segment, including physician practices, health systems, hospitals, ambulatory surgery centers, labs, and ancillary providers, processing billions of healthcare payment transactions annually.

Waystar became a publicly traded company on June 7, 2024, listing on the Nasdaq Global Select Market under the ticker symbol "WAY." Led by CEO Matt Hawkins, the company continues to position itself as a leader in end-to-end RCM software, emphasizing innovation and AI integration. Recent financial reports for Q1 2026 showed a 22% year-over-year revenue increase, with AI-powered capabilities driving a significant portion of new bookings and revenue, further solidifying its market standing and strategic investments in advanced technology.

Latest updates

Waystar's Growth Accelerates, But Volume-Based Revenue Lags

Event summary

  • Waystar reported Q1 2026 revenue of $313.9 million, a 22% year-over-year increase.
  • The company achieved a non-GAAP net income of $81.2 million and an adjusted EBITDA margin of 43%.
  • Subscription revenue grew 38% year-over-year to $172.2 million, while volume-based revenue increased by only 7% to $139.5 million.
  • Waystar anticipates full-year 2026 revenue between $1.274 billion and $1.294 billion and adjusted EBITDA between $530 million and $540 million.

The big picture

Waystar's strong Q1 results highlight the increasing reliance on software solutions within the healthcare payments sector. The company's shift towards subscription-based revenue models demonstrates a broader trend in the industry, but the slower growth in volume-based revenue suggests potential headwinds. With $313.9 million in quarterly revenue, Waystar's performance is being closely watched as a bellwether for the broader healthcare technology market.

What we're watching

Revenue Mix
The divergence in growth rates between subscription and volume-based revenue warrants scrutiny; a continued slowdown in volume-based revenue could pressure margins and overall growth.
Integration Risk
The success of the Iodine integration will be crucial for Waystar's future growth, and any integration challenges could negatively impact financial performance.
Competitive Landscape
The healthcare payments space is becoming increasingly competitive, and Waystar's ability to maintain its market share and pricing power will depend on continued innovation and customer retention.

Waystar Advances Autonomous Revenue Cycle, Aims to Tackle $40 Billion Recoupment Problem

Event summary

  • Waystar showcased new AI-powered capabilities targeting automation of the healthcare revenue cycle.
  • The company claims AltitudeAI is preventing $15.5 billion in denials and reducing denial appeals recovery time by 90%.
  • A new solution aims to address $40 billion in annual payer take-backs (recoupments) by automatically matching claims.
  • Early adopters of the recoupment solution matched $32 million in revenue risk, equivalent to 13 full-time employees.
  • Waystar’s platform processes over 7.5 billion transactions annually, representing approximately 60% of U.S. patients.

The big picture

Waystar is positioning itself as a leader in applying AI to a notoriously complex and fragmented industry. The company's focus on automating the revenue cycle addresses a critical pain point for healthcare providers struggling with administrative burdens and shrinking margins. The $40 billion recoupment problem represents a significant opportunity, but also a regulatory and operational challenge that requires precise execution.

What we're watching

Adoption Rate
The success of Waystar’s autonomous revenue cycle hinges on provider adoption of AltitudeAI, and the pace of integration will determine the realization of claimed ROI.
Recoupment Accuracy
The effectiveness of the new recoupment solution depends on the accuracy of AI-driven claims matching, and any misidentification could lead to legal or regulatory scrutiny.
Competitive Response
Other healthcare payment software providers will likely accelerate their AI investments in response to Waystar’s advancements, potentially intensifying competition and eroding Waystar’s market share.

Waystar to Report Q1 2026 Results Amid Healthcare Payment Consolidation

Event summary

  • Waystar Holding Corp. (Nasdaq: WAY) will report Q1 2026 financial results on April 29, 2026, after market close.
  • A conference call to discuss results is scheduled for 4:30 p.m. ET on the same day.
  • Waystar processes over 7.5 billion healthcare payment transactions annually, totaling over $2.4 trillion in gross claims.
  • The company serves over 30,000 clients, representing over 1 million providers, including 16 of 20 U.S. News Best Hospitals.

The big picture

Waystar operates in a critical but complex niche within the healthcare ecosystem, facilitating a significant portion of U.S. healthcare payments. The company's scale provides a degree of defensibility, but also exposes it to regulatory and competitive pressures. The upcoming earnings call will provide insight into how Waystar is navigating these challenges and capitalizing on the ongoing digitization of healthcare.

What we're watching

Market Dynamics
The healthcare payments landscape is undergoing consolidation, and Waystar's ability to maintain its market share and pricing power will be critical to observe during the earnings call.
Client Retention
Given the scale of Waystar’s client base, any significant client attrition could materially impact revenue, and the company’s commentary on retention rates will be closely scrutinized.
Regulatory Risk
Increased regulatory scrutiny around data privacy and payment processing within the healthcare sector could necessitate costly compliance measures and impact Waystar’s profitability.

Waystar Leverages AI to Tackle $40 Billion in 'Silent Denial' Recoupments

Event summary

  • Waystar introduced AltitudeAI™, an AI-powered solution targeting $40 billion in annual provider revenue lost to payer recoupments.
  • The solution has reduced reconciliation time by over 80% in early deployments, surfacing $32 million in previously hidden recoupments for one health system.
  • Payer recoupments are growing at twice the rate of overall claim volume, creating a significant administrative burden for providers.
  • Waystar's platform processes over 7.5 billion healthcare payment transactions annually, representing approximately 60% of U.S. patients.

The big picture

Waystar's move highlights a growing problem in healthcare: 'silent denials' through payer recoupments, which are often opaque and difficult for providers to manage. By leveraging its massive transaction dataset and AI, Waystar is positioning itself as a critical intermediary in the healthcare payments ecosystem, potentially disrupting traditional revenue cycle management workflows. The solution's success could force payers to be more transparent about recoupment practices, or face increased scrutiny and pressure from providers.

What we're watching

Adoption Rate
The success of AltitudeAI hinges on provider adoption; widespread implementation will be crucial to realizing the stated $40 billion recovery potential.
Payer Response
How payers react to Waystar's increased visibility into recoupment practices will determine the long-term viability of the solution and potential for pushback.
Competitive Landscape
Other healthcare payment processors may attempt to replicate Waystar's AI capabilities, potentially eroding Waystar’s competitive advantage in the revenue cycle management space.

Waystar Integrates Google's Gemini AI to Automate Healthcare Revenue Cycle

Event summary

  • Waystar is expanding its collaboration with Google Cloud to integrate Google's Gemini AI models into its revenue cycle workflows.
  • Waystar's AltitudeAI platform has already prevented over $15 billion in denied claims and reduced denial appeal time by 90%.
  • The partnership aims to accelerate Waystar's development of agentic AI capabilities and move towards an autonomous revenue cycle.
  • Waystar processes over 7.5 billion healthcare payment transactions annually, representing approximately 60% of U.S. patients.

The big picture

Waystar's partnership with Google Cloud represents a significant step towards automating a traditionally complex and inefficient process within healthcare. The move underscores the growing importance of AI in streamlining financial operations for healthcare providers and reducing administrative burdens. The scale of Waystar's existing data processing infrastructure – over $2.4 trillion in annual gross claims – positions them to benefit significantly from Google's advanced AI models, but also creates a large target for regulatory oversight.

What we're watching

Execution Risk
The successful integration of Gemini's agentic capabilities into Waystar's workflows will be critical; challenges in data compatibility or model performance could impede progress towards full automation.
Competitive Landscape
Other healthcare payment software providers will likely accelerate their own AI initiatives in response to Waystar's advancements, potentially intensifying competition for market share.
Regulatory Scrutiny
As Waystar's AI agents take on more decision-making responsibilities within the revenue cycle, increased regulatory scrutiny regarding data privacy, algorithmic bias, and transparency is likely.

Waystar AI Dominates RCM, Signals Shift to Autonomous Revenue Cycle

Event summary

  • Waystar's AI capabilities, specifically AltitudeAI™, achieved the top ranking in a Black Book survey of 49 revenue cycle management (RCM) vendors.
  • The survey, based on insights from over 750 healthcare leaders, gave Waystar a composite score of 9.75 out of 10, significantly outperforming the next competitor at 8.27.
  • AltitudeAI™ has reportedly prevented $15 billion in denials and accelerated appeal package generation by 90% in less than a year.
  • Nearly 100% of surveyed leaders indicated a high likelihood of renewing their AI engagements with Waystar.

The big picture

Waystar's dominance in AI-powered RCM reflects a broader trend in healthcare towards automation and data-driven decision-making. The company's AltitudeAI™ platform, with its reported $15 billion denial prevention impact, highlights the potential for AI to significantly improve financial performance for healthcare providers. This success positions Waystar to capitalize on the growing demand for intelligent revenue cycle solutions, but also underscores the increasing importance of AI governance and ethical considerations within the healthcare sector.

What we're watching

Autonomous Operations
Waystar's stated focus on a 'fully autonomous revenue cycle' suggests a long-term strategy to minimize human intervention, which could significantly impact labor costs and operational efficiency but also introduces new risks related to algorithmic bias and error handling.
Competitive Response
The substantial lead in client satisfaction and renewal rates will likely prompt competitors to accelerate their AI investments and differentiation strategies, potentially leading to increased pricing pressure or feature parity over time.
Data Dependency
Waystar's success is attributed to 'unmatched proprietary data'; the company's ability to maintain and expand this data advantage will be crucial for sustaining its competitive edge and avoiding regulatory scrutiny related to data privacy and usage.

Waystar's AI Push Accelerates, Margin Expansion a Key Focus

Event summary

  • Waystar reported Q4 revenue of $304M, up 24% year-over-year, and FY revenue of $1,099M, up 17% year-over-year.
  • The company achieved a Q4 adjusted EBITDA margin of 43% and a FY adjusted EBITDA margin of 42%.
  • Waystar integrated the Iodine acquisition ahead of schedule, citing it as a driver of growth.
  • The company is guiding for FY 2026 revenue between $1.274 billion and $1.294 billion and adjusted EBITDA between $530 million and $540 million.

The big picture

Waystar's strong growth and margin expansion underscore the increasing demand for automated revenue cycle management solutions within the healthcare sector. The acquisition of Iodine signals a strategic bet on AI-driven capabilities, positioning Waystar to capitalize on the broader trend of digital transformation in healthcare. However, the company's valuation will be sensitive to its ability to execute on its AI roadmap and maintain its competitive advantage in a rapidly evolving market.

What we're watching

AI Adoption
The success of Waystar's AI-powered platform will hinge on provider adoption rates and the ability to demonstrate tangible ROI beyond current claims.
Margin Sustainability
Whether Waystar can maintain its high adjusted EBITDA margins as it scales and continues to invest in AI development and integration remains a key risk.
Client Retention
The net revenue retention rate, currently at 112%, will need to remain robust to validate the stickiness of Waystar's solutions and offset potential churn.

Waystar's AI Gains Drive $15.5B in Denials Prevention

Event summary

  • Waystar has been recognized as an Inc. Best in Business honoree in the AI Implementation category.
  • AltitudeAI, Waystar's AI suite, has prevented $15.5 billion in denials for clients.
  • Clients using AltitudeAI have achieved 95% time savings in denial prevention workflows and doubled denial overturn rates.
  • Advocate Health, a large health system, credits Waystar AltitudeAI for supporting its rapid growth.

The big picture

Waystar's recognition highlights the growing importance of AI in streamlining healthcare revenue cycles, a sector facing increasing pressure to reduce administrative costs and improve efficiency. The $15.5 billion in prevented denials underscores the potential for AI to deliver substantial financial impact, but also raises questions about the scalability of these results and the potential for broader industry adoption. Waystar’s success is tied to its ability to leverage its unique position within the payment flow to build a defensible AI advantage.

What we're watching

Autonomous Future
Waystar's stated goal of an 'autonomous revenue cycle' represents a significant shift; tracking progress toward this vision will be key to assessing long-term competitive advantage and potential disruption of existing workflows.
Data Moat
The company emphasizes its proprietary data asset as a barrier to entry; monitoring Waystar’s ability to maintain and expand this data advantage will be crucial in evaluating its defensibility against larger, well-funded competitors.
Client Retention
While Advocate Health's testimonial is positive, sustained client adoption and retention of AltitudeAI will be essential to validate the ROI claims and justify Waystar's premium pricing.

Waystar Extends KLAS Dominance Amid Healthcare Payment Complexity

Event summary

  • Waystar has been recognized as Best in KLAS for Patient Access for the eleventh consecutive year.
  • The company's AI-powered platform addresses a $10 billion annual problem for hospitals related to payer authorization requirements.
  • Waystar AltitudeAI leverages a large healthcare payment dataset to automate workflows and improve revenue cycle management.
  • Clients report a 55% reduction in eligibility-related denials and up to 90% auto-approval rates for prior authorizations.
  • Waystar processes over $2.4 trillion in annual gross claims and serves over 30,000 clients, representing over 1 million providers.

The big picture

Waystar's consistent recognition highlights the growing need for automation and AI-driven solutions within the complex U.S. healthcare payment system. The company's ability to address front-end financial challenges, which account for a significant portion of denials, positions it as a critical vendor for hospitals struggling with declining margins and administrative burdens. The reliance on a proprietary dataset for AltitudeAI creates a potential moat, but also introduces regulatory and data security risks.

What we're watching

Competitive Landscape
The continued dominance of Waystar in the Patient Access space will likely intensify competition, prompting rivals to accelerate their AI and automation investments to retain or gain market share.
AltitudeAI Adoption
The pace at which Waystar can expand adoption of AltitudeAI across its client base will be a key driver of future revenue growth and will determine its ability to maintain its Best in KLAS status.
Regulatory Risk
Increased regulatory scrutiny around the use of AI in healthcare, particularly concerning data privacy and algorithmic bias, could impact Waystar's ability to leverage its large dataset and maintain its competitive advantage.

Waystar to Report FY25 Results Amid Healthcare Payment Consolidation

Event summary

  • Waystar Holding Corp. (Nasdaq: WAY) will report Q4 and FY25 financial results on February 17, 2026, before market open.
  • A conference call to discuss the results is scheduled for 8:30 a.m. ET on the same day.
  • Waystar processes over 7.5 billion healthcare payment transactions annually, representing $2.4 trillion in gross claims.
  • The company serves over 30,000 clients, including 16 of 20 institutions on the U.S. News Best Hospitals list.

The big picture

Waystar operates in a critical, but complex, segment of the healthcare ecosystem. The company’s scale—processing trillions in claims—positions it as a key player, but also exposes it to regulatory and competitive pressures. The upcoming earnings call will provide insight into how Waystar is navigating these challenges and capitalizing on the ongoing shift towards digital healthcare payments.

What we're watching

Market Dynamics
The healthcare payments landscape is undergoing consolidation, and Waystar’s results will reveal whether it’s gaining or losing share in this evolving environment.
Client Retention
Given the criticality of Waystar’s software, client retention rates will be a key indicator of its long-term stability and pricing power.
Regulatory Risk
Increased regulatory scrutiny around healthcare data and payments could impact Waystar's operational costs and necessitate further investment in compliance.

Waystar Automates Revenue Cycle with Agentic AI, Targets Nursing Shortage Relief

Event summary

  • Waystar introduced agentic intelligence to its AltitudeAI platform, aiming for a fully autonomous revenue cycle.
  • The company claims AltitudeAI has prevented $15.5 billion in claim denials in under one year.
  • The new agentic AI workflow is projected to reduce manual correction workload by approximately 40%.
  • Waystar processes over 7.5 billion annual transactions and handles one in three U.S. hospital discharges.

The big picture

Waystar's move towards an autonomous revenue cycle reflects a broader trend in healthcare technology towards automation and AI-driven solutions, driven by rising administrative costs and persistent labor shortages. The company's large dataset and existing AltitudeAI platform provide a significant advantage, but the complexity of healthcare workflows presents a substantial implementation challenge. This initiative directly addresses the growing pressure on healthcare systems to improve efficiency and reduce operational burdens, particularly as nursing shortages intensify.

What we're watching

Implementation Risk
The success of agentic AI hinges on seamless integration across Waystar's existing platform and client workflows; early adoption challenges could slow the rollout.
Competitive Response
Other healthcare payment software providers will likely accelerate their AI development efforts, potentially eroding Waystar's competitive advantage.
Cost Savings
The actual cost savings realized by Waystar's clients from the new agentic AI workflow will be a key indicator of the technology's long-term value proposition.

Waystar CEO to Address J.P. Morgan Healthcare Conference

Event summary

  • Waystar CEO Matt Hawkins will present at the J.P. Morgan Healthcare Conference on January 12, 2026.
  • The presentation will be webcast live and recorded for later viewing on Waystar’s investor relations website.
  • Waystar processes over 6 billion healthcare payment transactions annually, totaling $1.8 trillion in gross claims.
  • The company serves approximately 30,000 clients, representing over 1 million providers, including 16 of 20 U.S. News Best Hospitals.

The big picture

Waystar’s presence at J.P. Morgan Healthcare Conference underscores the growing importance of specialized payment solutions within the healthcare industry. The company’s scale—processing nearly 50% of U.S. patient payments—positions it as a key player, but also exposes it to regulatory and competitive pressures. The conference provides a platform to articulate strategy and address investor concerns regarding long-term growth and profitability.

What we're watching

Growth Trajectory
The conference presentation will likely address Waystar’s growth strategy given the substantial transaction volume and client base, and whether expansion can continue at the current pace.
Competitive Landscape
Increased scrutiny of healthcare pricing and payment practices may intensify competition within the payment software sector, potentially impacting Waystar’s market share.
Regulatory Risk
Changes in healthcare regulations surrounding data privacy and payment processing could necessitate adjustments to Waystar’s platform and increase compliance costs.
CID: 365